Erica Schmidt*
Myocardial infarction, commonly known as a heart attack, is a leading cause of morbidity and mortality worldwide. Early detection and prompt diagnosis play a crucial role in the effective management of myocardial infarction, as it enables timely intervention and improves patient outcomes. Traditional biomarkers, such as troponins and creatine kinase, have been widely used for diagnosing myocardial infarction. However, the quest for more sensitive and specific biomarkers has led to the discovery of novel biomarkers that can provide valuable insights into the pathophysiology and early detection of myocardial infarction. This research article aims to review and discuss the impact of these novel biomarkers in the early detection and diagnosis of myocardial infarction, highlighting their potential clinical applications and future directions.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 